Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LGALS9 | O00182 | 2/20 | 0.38 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.38 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.38 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | SELP | P16109 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16581621 | 1.00 | L3MBTL1 (0.47) | L3MBTL1KMT2AMEN1LGALS9LGALS1 | |
| SCHEMBL5828119 | 1.00 | L3MBTL1 (0.47) | L3MBTL1KMT2AMEN1LGALS9LGALS1 | |
| SCHEMBL16593160 | 1.00 | L3MBTL1 (0.47) | L3MBTL1KMT2AMEN1LGALS9LGALS1 | |
| SCHEMBL13024785 | 0.95 | L3MBTL1 (0.52) | L3MBTL1KMT2AMEN1LGALS9LGALS1 | |
| SCHEMBL26491385 | 0.92 | L3MBTL1 (0.43) | L3MBTL1KMT2AMEN1LGALS9LGALS1 | |
| SCHEMBL20936341 | 0.92 | KMT2A (0.49) | L3MBTL1KMT2AMEN1LGALS9LGALS1 | |
| SCHEMBL13024817 | 0.92 | L3MBTL1 (0.43) | L3MBTL1KMT2AMEN1LGALS9LGALS1 | |
| SCHEMBL18101893 | 0.92 | L3MBTL1 (0.43) | L3MBTL1KMT2AMEN1LGALS9LGALS1 | |
| SCHEMBL6704344 | 0.92 | L3MBTL1 (0.50) | L3MBTL1KMT2AMEN1LGALS9LGALS1 | |
| SCHEMBL6704580 | 0.92 | KMT2A (0.49) | L3MBTL1KMT2AMEN1LGALS9LGALS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170239341-A1 | VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 8 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2017-08-24 | — | — | US | disclosed |
| US-20160279224-A1 | PROTEIN AND PEPTIDE-FREE SYNTHETIC VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE TYPE 3 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2016-09-29 | — | — | US | disclosed |
| WO-2016046420-A1 | VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 8 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2016-03-31 | — | — | WO | disclosed |
| EP-3000820-A1 | Synthetic vaccines against Streptococcus pneumoniae serotype 8 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2016-03-30 | — | — | EP | disclosed |
| WO-2015040140-A1 | PROTEIN AND PEPTIDE-FREE SYNTHETIC VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE TYPE 3 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2015-03-26 | — | — | WO | disclosed |
| EP-2851092-A1 | Protein and peptide-free synthetic vaccines against streptococcus pneumoniae type 3 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2015-03-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170239341-A1 | VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 8 | LGALS8, SIGLEC7, FUT5 | L3MBTL1 2417/4885KMT2A 3584/4885MEN1 2902/4885 |
| US-20160279224-A1 | PROTEIN AND PEPTIDE-FREE SYNTHETIC VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE TYPE 3 | STT3A, DDOST, LGALS3BP | L3MBTL1 2714/4885KMT2A 3980/4885MEN1 2043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.